TMEDvsPJPETF Comparison
VS
T. Rowe Price Health Care ETF (TMED) and Invesco Dynamic Pharmaceuticals ETF (PJP) belong to the same industry segment: US Health Care. TMED's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Non-Corporate. In contrast, PJP's top sector exposures are Healthcare. TMED is less expensive with a Total Expense Ratio (TER) of 0.44%, versus 0.58% for PJP. TMED is up 17.46% year-to-date (YTD) with +$13M in YTD flows. PJP performs better with 21.39% YTD performance, and +$167M in YTD flows. Run a side-by-side ETF comparison of TMED and PJP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
TMED vs PJP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/08/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | TMED PJP | -1.44%+0.54% | +11.05%+12.94% | +17.46%+21.39% | +35.43%+37.66% | n/a+69.22% | n/a+66.22% |
| Flows | TMED PJP | +$4M+$44M | +$10M+$156M | +$13M+$167M | +$15M+$182M | -+$114M | --$32M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | TMED PJP | +18.14%+18.23% | +18.39%+17.12% | n/a+16.34% | n/a+16.46% |
| Max drawdown | TMED PJP | -4.97%-5.27% | -11.09%-9.42% | n/a-16.11% | n/a-17.41% |
| Max drawdown duration | TMED PJP | 20d20d | 125d108d | n/a275d | n/a788d |
Trading data
TMED | PJP | |
Last sale 9/10/2026 at 1:30 PM | $34.00 | $124.74 |
| Previous close 09/09/2026 | $34.39 | $126.25 |
| Consolidated volume 09/09/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
TMED
is actively managed and doesn’t replicate an indexTMED | PJP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/10/2026 at 1:30 PM
Live
Closed
TMED | PJP | |
|---|---|---|
| Last price | $34.00 | $124.74 |
| 1D performance | -1.13% | -1.20% |
| AuM | $33.12 M | $554.00 M |
| E/R | 0.44% | 0.58% |
Characteristics
TMED | PJP | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | T. Rowe Price | Invesco |
| Benchmark | - | Dynamic Pharmaceutical Intellidex Index |
| N° of holdings | 97 | 28 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 11, 2025 | June 23, 2005 |
| ESG | No | No |
Advertisement
Exposure
Countries
TMED
USA
93.59%
Other
6.41%
PJP
USA
94.69%
Other
5.31%
Sectors
TMED
Healthcare
98.58%
Other
1.42%
PJP
Healthcare
100%
Other
-0%
Advertisement
Diversification
TMED
Total weight of top 15 holdings out of 15
61.11%
PJP
Total weight of top 15 holdings out of 15
65.5%
Top 15 holdings
Data as of July 31, 2026
TMED
Eli Lilly & Co.
16.65%
UnitedHealth Group, Inc.
5.89%
Thermo Fisher Scientific, Inc.
4.44%
Alnylam Pharmaceuticals, Inc.
4.11%
Gilead Sciences, Inc.
3.76%
Danaher Corp.
3.58%
Cencora, Inc.
3.30%
Insulet Corp.
2.73%
Agilent Technologies, Inc.
2.69%
DexCom, Inc.
2.66%
Dyne Therapeutics, Inc.
2.60%
Stryker Corp.
2.49%
West Pharmaceutical Services, Inc.
2.29%
Waters Corp.
2.20%
McKesson Corp.
1.72%
PJP
Abbott Laboratories
5.76%
AbbVie, Inc.
5.71%
Amgen, Inc.
5.33%
Johnson & Johnson
5.33%
Eli Lilly & Co.
5.25%
Merck & Co., Inc.
5.03%
Gilead Sciences, Inc.
4.58%
Pfizer Inc.
4.49%
Corcept Therapeutics, Inc.
4.00%
Amneal Pharmaceuticals, Inc.
3.88%
Liquidia Corp.
3.75%
Travere Therapeutics, Inc.
3.26%
Ligand Pharmaceuticals, Inc.
3.18%
Harmony Biosciences Holdings, Inc.
3.10%
Viatris, Inc.
2.85%
Frequently asked questions about TMED and PJP
How have the TMED and PJP ETFs performed in 2026?
As of September 8, 2026, TMED is up 17.46% year-to-date (YTD), while PJP has returned 21.39%. That puts PJP better performer ahead so far this year.
Which ETF is attracting more investor money: TMED or PJP?
Year-to-date, the TMED ETF saw +$13M in flows, compared to +$167M for PJP.
Which ETF is more volatile: TMED or PJP?
Over the past year, TMED had a volatility of 18.39%, while PJP experienced 17.12%.
Which ETF is bigger: TMED or PJP?
As of September 8, 2026, TMED holds $33.12 M in assets under management (AUM), while PJP manages $554.00 M.
What sectors do the TMED and PJP ETFs invest in?
TMED leans toward sectors like Healthcare. Meanwhile, PJP focuses on Healthcare.
What are the top holdings of the TMED ETF and PJP ETF?
TMED top holdings include Eli Lilly & Co., UnitedHealth Group, Inc. and Thermo Fisher Scientific, Inc.. PJP holds in its top three: Abbott Laboratories, AbbVie, Inc. and Amgen, Inc..
Which ETF is more diversified: TMED or PJP?
TMED holds 97 securities with 61.11% of its assets in the top 15. PJP has 28 securities and a top 15 weight of 65.5%.
Advertisement
Advertisement
